Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group Market Cap: 45.43B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 45.43B |
| October 31, 2024 | 44.47B |
| October 30, 2024 | 44.60B |
| October 29, 2024 | 45.10B |
| October 28, 2024 | 45.84B |
| October 25, 2024 | 46.10B |
| October 24, 2024 | 46.24B |
| October 23, 2024 | 44.90B |
| October 22, 2024 | 45.01B |
| October 21, 2024 | 45.11B |
| October 18, 2024 | 46.05B |
| October 17, 2024 | 45.79B |
| October 16, 2024 | 44.65B |
| October 15, 2024 | 44.74B |
| October 14, 2024 | 45.36B |
| October 11, 2024 | 44.26B |
| October 10, 2024 | 43.83B |
| October 09, 2024 | 44.57B |
| October 08, 2024 | 44.37B |
| October 07, 2024 | 44.25B |
| October 04, 2024 | 44.34B |
| October 03, 2024 | 44.99B |
| October 02, 2024 | 45.03B |
| October 01, 2024 | 45.69B |
| September 30, 2024 | 45.56B |
| Date | Value |
|---|---|
| September 27, 2024 | 45.96B |
| September 26, 2024 | 46.15B |
| September 25, 2024 | 45.14B |
| September 24, 2024 | 45.66B |
| September 23, 2024 | 45.51B |
| September 20, 2024 | 45.09B |
| September 19, 2024 | 46.13B |
| September 18, 2024 | 45.37B |
| September 17, 2024 | 45.83B |
| September 16, 2024 | 47.19B |
| September 13, 2024 | 47.19B |
| September 12, 2024 | 46.15B |
| September 11, 2024 | 46.90B |
| September 10, 2024 | 46.77B |
| September 09, 2024 | 46.15B |
| September 06, 2024 | 45.83B |
| September 05, 2024 | 45.44B |
| September 04, 2024 | 45.89B |
| September 03, 2024 | 45.64B |
| August 30, 2024 | 47.14B |
| August 29, 2024 | 47.09B |
| August 28, 2024 | 47.47B |
| August 27, 2024 | 47.24B |
| August 26, 2024 | 47.19B |
| August 23, 2024 | 47.48B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
24.01B
Minimum
Mar 23 2020
63.43B
Maximum
Aug 27 2021
42.86B
Average
43.48B
Median
Market Cap Benchmarks
| AC Immune SA | 296.82M |
| CRISPR Therapeutics AG | 4.323B |
| Addex Therapeutics Ltd | 11.44M |
| NLS Pharmaceutics Ltd | 13.73M |
| Molecular Partners AG | 203.08M |
Market Cap Related Metrics
| PE Ratio | 71.05 |
| PS Ratio | 6.089 |
| Price to Book Value | 4.367 |
| Price | 62.99 |
| Earnings Yield | 1.41% |
| Operating PE Ratio | 47.30 |
| Normalized PE Ratio | 63.03 |